Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 23;24(4):102293.
doi: 10.1016/j.isci.2021.102293. Epub 2021 Mar 9.

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

Affiliations

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

Xiaoyuan Lin et al. iScience. .

Abstract

Recently, COVID-19 caused by the novel coronavirus SARS-CoV-2 has brought great challenges to the world. More and more studies have shown that patients with severe COVID-19 may suffer from cytokine storm syndrome; however, there are few studies on its pathogenesis. Here we demonstrated that SARS-CoV-2 coding protein open reading frame 8 (ORF8) acted as a contributing factor to cytokine storm during COVID-19 infection. ORF8 could activate IL-17 signaling pathway and promote the expression of pro-inflammatory factors. Moreover, we demonstrated that treatment of IL17RA antibody protected mice from ORF8-induced inflammation. Our findings are helpful to understand the pathogenesis of cytokine storm caused by SARS-CoV-2 and provide a potential target for the development of COVID-19 therapeutic drugs.

Keywords: Biological Sciences; Microbiology; Virology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
ORF8 promotes the secretion of inflammatory factors by activating IL-17 pathway (A) HEK293T cells were co-transfected with Myc-IL17RA and HA-NSP2/HA-ORF7a/HA-ORF8 for 24 h, and the interaction of IL17RA with NSP2/ORF7a/ORF8 was detected by immunoprecipitation. (B) GST pulldown analysis of the interaction between GST-ORF8 and Myc-IL17RA. (C) Il17ra+/+ PMs were treated with 1 μg/mL His-tagged NSP2/ORF7a/ORF8 for 24 h, and immunoprecipitation was performed to detect the interaction of IL17RA with NSP2/ORF7a/ORF8. (D) Il17ra+/+ PMs were treated with different concentrations of purified His-ORF8 protein for 24 h, and immunoprecipitation was performed to detect the interaction of IL17RA with ORF8. (E) Schematic diagram of IL17RA truncations. (F and G) Co-immunoprecipitation analysis of the interaction between ORF8 and IL17RA truncations in HEK293T cells co-transfected with HA-ORF8 and truncation plasmids for 24 h (F), or in Il17ra−/− RAW264.7 transfected with IL17RA truncation plasmids for 24 h, and treated with 1 μg/mL His-ORF8 protein for 24 h (G). (H–K) Il17a−/− RAW264.7 were treated with 50 ng/mL IL-17 or 0.1–1 μg/mL His-ORF8 protein as indicated for 24 h. The interaction between IL17RA and ACT1 was detected by co-immunoprecipitation (H); NF-κB activity was detected by dual luciferase reporter analysis (I); phosphorylation level of IκBα was detected by western blotting (J); and secretion of TNF-α, IL-1β, IL-6, and IL-12 was detected by ELISA analysis (K). Data are representative of three independent experiments (A–D, F–H, and J) or three independent experiments with n = 3 technical replicates (I and K) (shown as mean ± SEM in I and K). Individual data points represent individual technical replicates (I). Data are analyzed by two-tailed Student's t test (I and K). ∗∗p < 0.01.
Figure 2
Figure 2
IL17RA antibody protects mice from ORF8-induced inflammation (A and B) Il17a−/− RAW264.7 were treated with IL17RA antibody as indicated for 8 h and treated by 1 μg/mL His-ORF8 protein for 24 h. NF-κB activity was detected by dual luciferase reporter analysis (A), and the secretion of TNF-α, IL-1β, IL-6, and IL-12 was detected by ELISA (B). Blank: negative control; IL-17: cells were treated with 50 ng/mL IL-17 for 24 h; His-ORF8: cells were treated with 1 μg/mL His-ORF8 for 24 h; Isotype Ctrl: cells were treated with Isotype antibody of IL17RA for 8 h and further treated by 1 μg/mL His-ORF8 protein for 24 h. (C and D) Il17a-deficient C57BL/6 mice were intraperitoneally injected with 200 μg IL17RA antibody, and the injection was repeated every 3 days. After the second injection, mice were intratracheally infected with the adenovirus expressing ORF8 (108 PFU/mouse). The time was recorded as day 0. Afterward, lung (C) and liver (D) sections were taken every 3 days. The secretion of TNF-α, IL-1, IL-6, and IL-12 was detected by ELISA. (E and F) H&E staining in lung (E) and liver (F) sections on day 9 post-infection. The degree of organ damage was assessed by a scoring system. Scale bar, 400 μm. Data are representative of three independent experiments (E and F) or three independent experiments with n = 3 technical replicates (A–F) (shown as mean ± SEM in A–F). Individual data points represent individual technical replicates (A, B, E, and F). Data are analyzed by two-tailed Student's t test (A–F). ∗∗p < 0.01.

References

    1. Becker A., Thakur B.K., Weiss J.M., Kim H.S., Peinado H., Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836–848. - PMC - PubMed
    1. Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., Moller R., Jordan T.X., Oishi K., Panis M., Sachs D. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036–1045 e1039. - PMC - PubMed
    1. Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., Yuen K.Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microb. Infect. 2020;9:221–236. - PMC - PubMed
    1. Costa A., de Souza Carvalho-Wodarz C., Seabra V., Sarmento B., Lehr C.M. Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrier. Acta Biomater. 2019;91:235–247. - PubMed
    1. Crowe C.R., Chen K., Pociask D.A., Alcorn J.F., Krivich C., Enelow R.I., Ross T.M., Witztum J.L., Kolls J.K. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 2009;183:5301–5310. - PMC - PubMed